Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
D

Significant Medication Error Due to Improper Administration of Time-Release Capsule

San Dimas, California Survey Completed on 06-12-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when facility staff failed to ensure a resident was free from significant medication errors. Specifically, a Licensed Vocational Nurse (LVN) was observed opening a Macrobid (nitrofurantoin macrocrystals) 100 mg oral capsule, pouring its contents into a medication cup, and mixing it with applesauce prior to administration. This action disrupted the time-release mechanism of the medication, which was intended to be delivered in a specific manner for therapeutic effectiveness. The LVN acknowledged that opening capsules should only be done after verification with a pharmacist, as some capsules are not meant to be opened due to potential changes in drug efficacy and safety. The resident involved had multiple diagnoses, including rheumatoid arthritis, diabetes mellitus, and encephalopathy, and was assessed as having moderately impaired cognition. The resident required assistance with activities of daily living and supervision with mobility. The medication order for Macrobid specified administration by mouth, but did not indicate that the capsule should be opened or mixed with food. The Medication Administration Record confirmed that the resident received the medication in this altered form. Interviews with the LVN and the Director of Nursing (DON) confirmed that facility policy required clarification with a pharmacist before altering any capsule medication, especially antibiotics that are often time-released. The DON emphasized the importance of maintaining the intended formulation to ensure proper absorption and effectiveness. Review of facility policy and job descriptions further supported that medications were to be administered as prescribed and in accordance with regulatory guidelines.

An unhandled error has occurred. Reload 🗙